BioHealth News Archive
MEDA Education Session: “Primer on selling to hospitals”
Wednesday, February 02, 2022, 12:00pm - 01:30pm Winning over a hospital Value Analysis Committee or “VAC” is a must for companies targeting hospital customers. What does it…
Read MoreLet’s Discuss the “still” Soaring Healthcare Investments in 2021 and beyond
Jonny’s back! Despite the continuation of COVID -19 through 2021, 2021 was a spectacular year for venture fundraising. Investment in every healthcare sector set…
Read MoreAge-Tech & Digital Health Solutions: Fundamentals of Longevity Economy Market (Audio Descriptions) – YouTube
The Developing and Accelerating Age-Tech and Digital Health Solutions webinar series, hosted by NIA’s Small Business Program, offers research entrepreneurs and biotech small business…
Read MoreAvidea Merger with Vaccitech Provides New Opportunities for SNAPvax Platform · BioBuzz
One month after being acquired in a $40 million deal by U.K.-based Vaccitech plc, the team that was formerly part of Avidea Technologies continues…
Read MoreDetection of SARS-CoV-2 and other RNA Virus Using a Novel Improved RT-qPCR Method that Increases Sensitivity & Improves Safety
DNA or RNA-based diagnostic tests for infectious diseases are critical in modern medicine. The current gold standard for COVID-19 detection is testing SARS-CoV-2 viral…
Read MoreStem Cell Therapy for NEC – Dr. David Hackam | Maryland Stem Cell Research Fund – YouTube
Dr. David Hackam and his lab are utilizing human stem cell technologies to tackle the leading cause of death and disability in premature infants,…
Read MoreNIH Technology Accelerator Challenge (NTAC) | National Institute of Biomedical Imaging and Bioengineering
Prize Competition for Maternal Health NIBIB launched the NIH Technology Accelerator Challenge (NTAC) series of prize competitions to stimulate the design of new diagnostic…
Read MoreStructural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development | Immunology | Frontiers
Monoclonal antibodies (mAbs) have proven effective for the treatment of ebolavirus infection in humans, with two mAb-based drugs Inmazeb™ and Ebanga™ receiving FDA approval…
Read MoreJHU revises COVID-19 safety protocols ahead of spring semester | Hub
Johns Hopkins University is revising its safety protocols ahead of the start of the spring semester as it prepares to resume a broad range…
Read MoreOne Of America’s Richest Self-Made Women, Martine Rothblatt, Played Key Role In Week’s Historic Heart Transplant
When the University of Maryland Medical Center announced the first successful transplant of a heart that was grown in a genetically altered pig earlier…
Read MoreFirst pig-to-human heart transplant: what can scientists learn?
The first person to receive a transplanted heart from a genetically modified pig is doing well after the procedure last week in Baltimore, Maryland.…
Read MoreFounder and Executive Chairman of Emergent BioSolutions Announces Retirement
GAITHERSBURG, Md., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that Fuad El-Hibri, founder and executive chairman, has decided…
Read MoreBioSpace: Cartesian Aims to Propel RNA Cell Therapy with Combinations
Published: Jan 07, 2022 By Gail Dutton Cartesian Therapeutics is developing non-permanent cell therapies that can be used soon after diagnosis and address…
Read MoreInstitute for Bioscience and Biotechnology Research Receives $16.8M Investment from the National Institute of Standards and Technology
Fri, Jan 14, 2022 New Cooperative Agreement to Aid in the Development of Therapeutics and Vaccines, Improve Access to Medication The Institute…
Read MoreUnblock research bottlenecks with non-profit start-ups
It takes more than a great idea to accomplish a great project. Our research and experience have convinced us that many worthy projects wither…
Read More